Discuss This Drug

lanreotide

CHEBI:CHEBI_135901

Chemical Information

Molecular Formula
C54H69N11O10S2
Molecular Mass
1096.328
Charge
0
SMILES
C(N[C@H]1CSSC[C@H](NC([C@H](C(C)C)NC([C@H](CCCCN)NC([C@H](NC([C@@H](NC1=O)CC2=CC=C(O)C=C2)=O)CC3=CNC4=C3C=CC=C4)=O)=O)=O)C(N[C@@H]([C@@H](C)O)C(N)=O)=O)(=O)[C@](N)([H])CC=5C=C6C=CC=CC6=CC5
InChI
InChI=1S/C54H69N11O10S2/c1-29(2)45-54(75)63-44(53(74)65-46(30(3)66)47(57)68)28-77-76-27-43(62-48(69)38(56)23-32-15-18-33-10-4-5-11-34(33)22-32)52(73)60-41(24-31-16-19-36(67)20-17-31)50(71)61-42(25-35-26-58-39-13-7-6-12-37(35)39)51(72)59-40(49(70)64-45)14-8-9-21-55/h4-7,10-13,15-20,22,26,29-30,38,40-46,58,66-67H,8-9,14,21,23-25,27-28,55-56H2,1-3H3,(H2,57,68)(H,59,72)(H,60,73)(H,61,71)(H,62,69)(H,63,75)(H,64,70)(H,65,74)/t30-,38+,40+,41+,42-,43+,44+,45+,46+/m1/s1
InChIKey
PUDHBTGHUJUUFI-PURAGXGVSA-N

Alternative Names

  • angiopeptin
  • ipstyl
  • lanreotide acetate
  • lanreotide autogel
  • somatulin-autogel
  • somatuline

Treatment Applications

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

DRON_00010000
68092
oboInOwl#hasDbXref
Drug_Central:1546
core#notation
CHEBI:135901

Additional References

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
68092
oboInOwl#hasDbXref
Drug_Central:1546
oboInOwl#id
CHEBI:135901
generic_name
Lanreotide Acetate
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20241231
dosage_form
INJECTION
marketing_start_date
20211224
route
SUBCUTANEOUS
labeler_name
Chengdu Shengnuo Biopharm Co., Ltd.
brand_name
Lanreotide Acetate
brand_name_base
Lanreotide Acetate
product_ndc
76282-720
application_number
NDA215395
spl_id
c9585c21-0ff5-f7c6-e053-2995a90a4d1d
package_ndc
76282-720-67
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#2_STAR
core#notation
CHEBI:135901
rxcui
749818
package_marketing_start_date
20211224
active_ingredient_strength
120 mg/.5mL
manufacturer_name
Cipla USA Inc.
active_ingredient_name
LANREOTIDE ACETATE
package_description
1 POUCH in 1 CARTON (76282-720-67) / 1 SYRINGE in 1 POUCH / .5 mL in 1 SYRINGE
unii
IEU56G3J9C
spl_set_id
2892b4c3-0329-4d29-97ff-3b45283bbab1
pharm_class
Somatostatin Receptor Agonists [MoA]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
has_treatment
http://purl.obolibrary.org/obo/DOID_5784
owl#someValuesFrom
t553774
rdf-schema#range
https://w3id.org/def/predibionto#has_drug_111573
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect4631
owl#annotatedSource
t108904